Slyepchenko et al. (2016) demonstrated that increased oxidative stress could induce neuroinflammation and contribute to the development of depression. Maes et al. (2011) also demonstrated that peripherally administered cytokines could reach the brain and lead the immune activation and ROS production via NFκB pathway. This evidence concerns the gene NFKB1 and major depressive disorder.